Catalyst Wire Dossier Catalyst Wire Dossier

rhFGF-2/HA

recombinant human fibroblast growth factor-2 with hydroxyapatite · Universidade Federal Fluminense
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhFGF-2/HA, covering 2015-01-13 to 2015-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Regeneration of Human Intrabony Defects With rhFGF-2/HA [Phase 1, Phase 2]

See pricing